BIOGROUP BALTICS, UAB - financials and debts

Company age: 14 y. 0 mo.

Update

BIOGROUP BALTICS - Company finances

EUR
2018
From: 2018-01-01
To: 2018-12-31
2019
From: 2019-01-01
To: 2019-12-31
2020
From: 2020-01-01
To: 2020-12-31
2021
From: 2021-01-01
To: 2021-12-31
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 275,655 196,101 231,193 294,456 301,923 391,315 443,428 496,450
Profit before tax 1,037,400 922,223 1,101,680 4,211,908 4,202,839 1,573,207 1,775,875 128,198
Net profit 1,035,244 922,223 1,101,680 4,211,908 4,202,839 1,573,207 1,775,875 128,198
Equity 15,795,928 16,118,151 16,219,831 19,031,739 20,934,578 21,007,785 21,183,660 20,511,858
Liabilities 218,604 188,305 191,906 136,955 147,710 114,698 173,817 119,159
Non-current assets 14,908,213 14,081,103 13,721,430 17,605,834 17,216,909 17,206,234 17,721,943 18,622,437
Current assets 1,103,655 2,219,782 2,680,934 1,547,870 3,851,056 3,898,332 3,625,469 1,982,311
Total assets 16,011,868 16,300,885 16,402,364 19,153,704 21,067,965 21,104,566 21,347,412 20,604,748
Taxes paid
STI taxes - - - - - 510,537 522,030 416,237
Social insurance contributions - - - - - 178,713 187,381 219,660
Financial indicators
Revenue change y/y +41.9% -28.9% +17.9% +27.4% +2.5% +29.6% +13.3% +12.0%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 6.5% 5.7% 6.7% 22.0% 19.9% 7.5% 8.3% 0.6%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 6.6% 5.7% 6.8% 22.1% 20.1% 7.5% 8.4% 0.6%
Profit margin Net profit margin. Shows the overall profitability of the company. 375.6% 470.3% 476.5% 1430.4% 1392.0% 402.0% 400.5% 25.8%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. 376.3% 470.3% 476.5% 1430.4% 1392.0% 402.0% 400.5% 25.8%
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. 29,801 23,532 28,899 31,270 29,697 39,132 45,872 41,954

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

Consolidated BIOGROUP BALTICS finance

EUR
2022
From: 2022-01-01
To: 2022-12-31
2023
From: 2023-01-01
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 60,865,336 50,758,718 56,464,062 42,909,138
Profit before tax 10,516,350 4,919,165 6,387,162 1,059,838
Net profit 5,496,331 2,165,084 2,973,744 -305,713
Equity 35,673,581 36,639,083 38,751,852 38,499,955
Liabilities 7,308,645 12,193,507 19,959,052 16,058,302
Non-current assets 14,997,771 18,748,280 26,195,525 25,903,209
Current assets 29,653,094 31,669,264 36,530,856 30,612,534
Total assets 44,650,865 50,417,544 62,726,381 56,515,743

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

BIOGROUP BALTICS - Social security debts

The company had no debts to Sodra

BIOGROUP BALTICS - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
BIOGROUP BALTICS, UAB (code 302864548) is a Private Limited Liability Company engaged in Activities of holding companies. In 2025, it generated revenue of EUR 496.4K, increasing by 12.0% year on year and by 26.9% over two years. Net profit was EUR 128.2K, giving a 25.8% margin. This followed much stronger results in 2024, when net profit reached EUR 1.78M, and in 2023, when profit was EUR 1.57M; in both years, profit exceeded revenue, indicating an unusually high profitability level. Total assets at the end of 2025 amounted to EUR 20.60M, compared with EUR 21.35M in 2024. Equity stood at EUR 20.51M and liabilities at EUR 119.2K, showing a highly equity-financed balance sheet. The equity ratio was 99.5% and debt-to-equity was 0.01. ROE and ROA were both 0.6%, while asset turnover was 0.02x. Revenue per employee was EUR 45.1K and profit per employee was EUR 11.7K.